---
title: "Bayer and Henry Ford Health partner to boost clinical trial access"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293199362.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-07-20T10:18:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293199362.md)
  - [en](https://longbridge.com/en/news/293199362.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293199362.md)
---

# Bayer and Henry Ford Health partner to boost clinical trial access

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [BAYRY.US](https://longbridge.com/en/quote/BAYRY.US.md)
- [BAYN.DE](https://longbridge.com/en/quote/BAYN.DE.md)
- [BAYZF.US](https://longbridge.com/en/quote/BAYZF.US.md)

## Related News & Research

- [Bayer Aktiengesellschaft (OTCMKTS:BAYRY) Short Interest Update](https://longbridge.com/en/news/294307068.md)
- [Bayer seeks China approval to expand Kerendia use to non-diabetic chronic kidney disease](https://longbridge.com/en/news/294312597.md)
- [Bayer plans 2027 launch of Bergkamen site-services operating unit](https://longbridge.com/en/news/294165865.md)
- [Amgen’s Repatha receives positive CHMP opinion for broader cardiovascular use](https://longbridge.com/en/news/294363759.md)
- [Pfizer seeks label expansion for Litfulo after double Phase III NSV win](https://longbridge.com/en/news/294400212.md)